Tc-99m DMSA renal scintigraphy was performed in 40 renal grafts. Cyclo
sporin A and glucocorticoids were given to all patients as antirejecti
on therapy, and 11 also were given azathioprine. The kidneys were tran
splanted 1 to 97 months before the investigation. Seventy percent of k
idneys had diffusely altered distribution of Tc-99m DMSA, and 43% had
focal clear-cut parenchymal defects. The frequency of parenchymal defe
cts observed on the DMSA scans was higher in patients who suffered man
ifest acute rejection episodes (8/16 versus 9/24 patients, borderline
significance, P < 0.06), but had no relation to the living or cadaveri
c donor transplant or its function. A combination of peritubular edema
and interstitial fibrosis is considered the most probable explanation
of diffuse changes. The high frequency of clear-cut parenchymal defec
ts most likely results from symptomatic or asymptomatic rejection epis
odes complicated by renal transplant infarcts.